Stock Research for AXIM

AXIM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AXIM Stock Chart & Research Data

The AXIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AXIM Due diligence Resources & Stock Charts

The AXIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AXIM Detailed Price Forecast - CNN Money CNN View AXIM Detailed Summary - Google Finance
Yahoo View AXIM Detailed Summary - Yahoo! Finance Zacks View AXIM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AXIM Trends & Analysis - Trade-Ideas Barrons View AXIM Major Holders - Barrons
NASDAQ View AXIM Call Transcripts - NASDAQ Seeking View AXIM Breaking News & Analysis - Seeking Alpha
Spotlight View AXIM Annual Report - CompanySpotlight.com OTC Report View AXIM OTC Short Report - OTCShortReport.com
TradeKing View AXIM Fundamentals - TradeKing Charts View AXIM SEC Filings - Bar Chart
WSJ View Historical Prices for AXIM - The WSJ Morningstar View Performance/Total Return for AXIM - Morningstar
MarketWatch View the Analyst Estimates for AXIM - MarketWatch CNBC View the Earnings History for AXIM - CNBC
StockMarketWatch View the AXIM Earnings - StockMarketWatch MacroAxis View AXIM Buy or Sell Recommendations - MacroAxis
Bullish View the AXIM Bullish Patterns - American Bulls Short Pains View AXIM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AXIM Stock Mentions - StockTwits PennyStocks View AXIM Stock Mentions - PennyStockTweets
Twitter View AXIM Stock Mentions - Twitter Invest Hub View AXIM Investment Forum News - Investor Hub
Yahoo View AXIM Stock Mentions - Yahoo! Message Board Seeking Alpha View AXIM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AXIM - SECform4.com Insider Cow View Insider Transactions for AXIM - Insider Cow
CNBC View AXIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AXIM - OTC Markets
Yahoo View Insider Transactions for AXIM - Yahoo! Finance NASDAQ View Institutional Holdings for AXIM - NASDAQ


Stock Charts

FinViz View AXIM Stock Insight & Charts - FinViz.com StockCharts View AXIM Investment Charts - StockCharts.com
BarChart View AXIM Stock Overview & Charts - BarChart Trading View View AXIM User Generated Charts - Trading View




Latest Financial News for AXIM


New U.S. Patent Allowance Granted to AXIM® Biotechnologies for Suppository Formulations Comprised of Cannabinoids
Posted on Tuesday October 23, 2018

NEW YORK, Oct. 23, 2018 -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that.


Axim® Biotechnologies Earns GMP License From Dutch Ministry of Health to Produce Cannabinoid-Based Pharmaceutical Products
Posted on Tuesday October 16, 2018

(“AXIM® Biotech” or “AXIM”) (AXIM), a world leader in cannabinoid research and development, today announced that it has received a manufacturing license from the Dutch Ministry of Health, Welfare and Sports for the production, according to Good Manufacturing Practices (“GMP”), of the company’s pharmaceutical products to be used in clinical trials. Effective Oct. 1, 2018, the license allows AXIM to produce its cannabinoid-based pharmaceutical drug candidates for use in human clinical trials for multiple indications.


The Only 2 Marijuana Stocks to Fall in September
Posted on Wednesday October 10, 2018

Though nearly every pot stock rose in September, these two weed stocks were outliers.


3 Things to Love and Hate About Medical Marijuana, Inc.'s Full-Year Report
Posted on Thursday May 03, 2018

It's another mixed bag for the first publicly traded pot stock in the U.S.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.